Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lactobacillus casei W56 |
?
Hepcidin and Erythroferrone Correlate with Hepatic Iron Transporters in Rats Supplemented with Multispecies Probiotics. Molecules (Basel, Switzerland) (Molecules ) Vol: 25 Issue 7 Pages: Pub: 2020 Apr 5 Epub: 2020 Apr 5 Authors Skrypnik K , Bogdanski P , Sobieska M , Suliburska J , Html Article Publication |
| Lactobacillus casei W56 |
?
Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial. Journal of translational medicine (J Transl Med ) Vol: 15 Issue 1 Pages: 249 Pub: 2017 Dec 11 Epub: 2017 Dec 11 Authors Sabico S , Al-Mashharawi A , Al-Daghri NM , Yakout S , Alnaami AM , Alokail MS , McTernan PG , Html Article Publication |
| Lactobacillus casei W56 |
?
Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial. Nutrients (Nutrients ) Vol: 8 Issue 11 Pages: Pub: 2016 Nov 23 Epub: 2016 Nov 23 Authors Strasser B , Geiger D , Schauer M , Gostner JM , Gatterer H , Burtscher M , Fuchs D , Html Article Publication |
| Lactobacillus casei W56 |
?
A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, behavior, and immunity (Brain Behav Immun ) Vol: 48 Issue Pages: 258-64 Pub: 2015 Aug Epub: 2015 Apr 7 Authors Steenbergen L , Sellaro R , van Hemert S , Bosch JA , Colzato LS , Publication |
| Lactobacillus casei W56 |
?
Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells. Beneficial microbes (Benef Microbes ) Vol: 1 Issue 2 Pages: 121-30 Pub: 2010 Jun Epub: Authors Malago JJ , Tooten PC , Koninkx JF , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.